Inhibitory effects and immunoregulation of Juglans mandshurica maxim extract on S180 mouse sarcoma

Journal of Jilin University Medicine Edition

Volumn 33, Issue 2, 2007, Pages 286-289

  Guo, Jian Hua ^a   Cui, Li Ming ^a   Li, Shu Hong ^a   Liu, Li ^a   He, Rong Hua ^a   Liu, Bing ^a  

^a JILIN UNIVERSITY   (China)

Author keywords

Interleukin 2; Juglans mandshurica maxim extract; Sarcoma 180; Tumor necrosis factor

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; INTERLEUKIN 2; JUGLANS MANDSHURICA MAXIM EXTRACT; PLANT EXTRACT; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL ASSAY; CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; IMMUNOREGULATION; IN VITRO STUDY; MOUSE; NONHUMAN; SARCOMA 180; TREATMENT OUTCOME; TUMOR IMMUNITY; WALNUT;

EID: 34247329429     PISSN: 1671587X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Chinese source.
2. Chinese source.
3. Chinese source.
4. Philip R, Epstein LB. Tumor necrosis factor as an immunodulator and mediator of monocyte cytoxicity induced by itself, gamma-interferon and interleukin-1 [J]. Nature, 1986, 322 (6083): 86-89.
5. Liu W, Chen SL, Liu JW, et al. Study of antimyeloma activity of interleukin-2 activated bone marrow in vitro [J]. 2003, 26 (4): 205-208.
6. Chinese source.
7. Chinese source.
8. Chinese source.